medical device approval in india | Who Approves Import Medical Device India 2026

Medical device approval in India – Medical device India industry is rapidly expanding, driven by a growing population, increasing healthcare needs, and advancements in medical technology. However, the regulatory framework for approving medical devices in India is stringent, ensuring safety, efficacy, and quality. At the heart of this process is the Central Drugs Standard Control Organization (CDSCO), supported by other regulatory bodies and overseen by the Drugs Controller General of India (DCGI). This article provides an in-depth exploration of the authorities responsible for approving medical devices in India, their roles, and the regulatory framework under the Medical Devices Rules (MDR), 2017.

Primary Regulatory Authority: Central Drugs Standard Control Organization (CDSCO)

The CDSCO, under the Ministry of Health and Family Welfare, is the apex regulatory body responsible for the approval, licensing, and post-market surveillance of medical devices in India. Established under the Drugs and Cosmetics Act, 1940, the CDSCO regulates both drugs and medical devices, ensuring compliance with safety and performance standards. For medical devices, the CDSCO administers the Medical Devices Rules (MDR), 2017, effective from January 1, 2018, which provide a structured framework for device classification, registration, and approval.

The CDSCO’s responsibilities include:

• Device Classification: Categorizing medical devices into risk-based classes (A, B, C, D) based on their intended use and risk profile, aligned with international standards like the International Medical Device Regulators Forum (IMDRF).
• Licensing: Issuing manufacturing licenses for Class C and D devices and import licenses for all classes.
• Application Review: Evaluating technical dossiers, clinical data, and quality management system (QMS) documentation.
• Post-Market Surveillance: Monitoring adverse events, conducting inspections, and ensuring compliance with MDR 2017.
• Policy Updates: Expanding the list of notified medical devices and updating regulatory guidelines.

The CDSCO operates through its headquarters in New Delhi (FDA Bhawan, Kotla Road) and regional offices across India. For businesses in Delhi seeking expert guidance, Satish Mehra, a seasoned regulatory consultant, offers comprehensive support for CDSCO processes. Contact him at +91-8920964801 (WhatsApp or call).

Role of the Drugs Controller General of India (DCGI)

The Drugs Controller General of India (DCGI) is the head of the CDSCO and serves as the final approving authority for medical devices in India. The DCGI oversees:

• Approval of Licenses: Grants manufacturing licenses (Form MD-9 for Class C/D) and import licenses (Form MD-15) after thorough review.
• Policy Implementation: Ensures adherence to MDR 2017 and updates regulations to align with global standards.
• Clinical Investigations: Approves clinical evaluation data for Class C and D devices to ensure safety and efficacy.
• Enforcement: Addresses non-compliance through inspections, recalls, or penalties.

The DCGI’s role is pivotal in maintaining the integrity of India’s medical device regulatory framework, balancing innovation with public safety.

State Licensing Authorities

For Class A (low risk, e.g., bandages, thermometers) and Class B (low-moderate risk, e.g., hypodermic needles) medical devices, the State Licensing Authorities play a significant role in the approval process. These authorities, operating under the oversight of the CDSCO, are responsible for issuing manufacturing licenses (Form MD-5) for Class A and B devices. Each state in India has its own licensing authority, typically part of the state’s drug control department.

The process involves:

• Reviewing applications submitted via the SUGAM portal (www.cdscoonline.gov.in).
• Verifying compliance with MDR 2017 requirements, including labeling and quality standards.
• Conducting site inspections for manufacturing facilities.

While State Licensing Authorities handle lower-risk devices, they report to the CDSCO to ensure consistency with national regulations. For complex queries or escalations, the CDSCO and DCGI may intervene.

Bureau of Indian Standards (BIS)

The Bureau of Indian Standards (BIS) collaborates with the CDSCO to ensure certain medical devices meet Indian quality standards. BIS certification is mandatory for specific devices, particularly those requiring compliance with Indian Standards (IS) for safety and performance. The BIS:

• Conducts testing at accredited laboratories to verify device quality.
• Issues certifications that support CDSCO applications, especially for imported devices.
• Aligns standards with international benchmarks like ISO and IEC.

For example, devices like surgical instruments or diagnostic equipment may require BIS certification alongside CDSCO approval. Manufacturers and importers must coordinate with BIS-accredited labs to complete testing requirements.

Medical Device Classification and Approval Process

To understand the approval process, it’s essential to know how medical devices are classified under MDR 2017:

• Class A: Low risk (e.g., bandages, tongue depressors)
• Class B: Low-moderate risk (e.g., suction equipment, catheters)
• Class C: Moderate-high risk (e.g., ventilators, orthopedic implants)
• Class D: High risk (e.g., pacemakers, heart valves)

The approval process varies by class and whether the device is manufactured domestically or imported:

1. Registration on SUGAM Portal

All applicants must register on the CDSCO’s SUGAM portal to initiate the approval process. This online platform streamlines application submission, fee payments, and communication with regulatory authorities.

2. Documentation and Compliance

• Quality Management System (QMS): For Class C and D devices, compliance with ISO 13485 (Quality Management System for Medical Devices) is mandatory, verified by a notified body.
• Technical Dossier: Includes device description, design details, clinical data (for Class C/D), risk analysis, labeling, and stability data.
• Imported Devices: Require additional documents like a Free Sale Certificate, CE marking, or US FDA approval, and an Authorized Indian Agent to represent the foreign manufacturer.

3. Application Submission

• Class A/B Devices:
  • Manufacturers apply to the State Licensing Authority for a manufacturing license (Form MD-5).
  • The process is faster, typically taking 3–6 months.
• Class C/D Devices:
  • Manufacturers apply to the CDSCO for a manufacturing license (Form MD-9).
  • Importers apply for an Import License (Form MD-15).
  • Approval takes 6–12 months due to rigorous evaluation.

4. Testing and Clinical Evaluation

• Devices may require testing at CDSCO-approved or BIS-accredited laboratories to ensure compliance with Indian standards.
• Class C and D devices need clinical evaluation data to demonstrate safety and efficacy. Global data may be accepted if India-specific data is unavailable, subject to DCGI approval.

5. License Issuance of medical device approval in india

• Upon successful review, licenses are issued:
  • Form MD-5: Manufacturing license for Class A/B (State Licensing Authority).
  • Form MD-9: Manufacturing license for Class C/D (CDSCO).
  • Form MD-15: Import license (CDSCO).
• Licenses are valid for 5 years and renewable.

6. Post-Market Surveillance

The CDSCO oversees post-market activities, requiring manufacturers and importers to report adverse events and comply with inspections. The DCGI may initiate recalls or penalties for non-compliance.

Supporting Roles and Stakeholders

• Notified Bodies: Independent organizations accredited by the CDSCO to audit QMS compliance (e.g., ISO 13485) for Class C and D devices.
• Authorized Indian Agents: Represent foreign manufacturers for imported devices, facilitating communication with the CDSCO.
• Testing Laboratories: CDSCO-approved or BIS-accredited labs conduct quality and safety tests.
• Regulatory Consultants: Experts like Satish Mehra (+91-8920964801, WhatsApp or call) in Delhi provide end-to-end support, from SUGAM registration to license issuance, ensuring compliance with CDSCO requirements.

Challenges in medical device approval in india

1. Complex Documentation: Preparing technical dossiers and clinical data can be daunting, especially for high-risk devices.
2. Evolving Regulations: The CDSCO frequently updates the list of notified devices, requiring manufacturers to stay informed.
3. Testing Infrastructure: Limited CDSCO-approved labs can cause delays.
4. Coordination: Navigating interactions between CDSCO, State Licensing Authorities, and BIS requires expertise.

Recent Developments

• Mandatory Registration: Since October 1, 2023, all medical devices (notified and non-notified) require registration under the CDSCO’s Voluntary Registration Scheme until they are officially notified.
• Digital Health Focus: The CDSCO is streamlining approvals for software-based medical devices, aligning with India’s digital health initiatives.
• Global Harmonization: MDR 2017 aligns with international standards, facilitating approvals for devices with CE marking or US FDA clearance.

Why Work with a Consultant in Delhi?

Delhi, as the location of CDSCO’s headquarters, is a strategic hub for regulatory activities. Engaging a local expert like Satish Mehra (+91-8920964801) ensures:

• Proximity to CDSCO for faster query resolution.
• Expertise in navigating SUGAM portal and MDR 2017 requirements.
• Support for BIS certification and clinical evaluations.
• Streamlined coordination with State Licensing Authorities and notified bodies.

Conclusion medical device approval in india

The approval of Medical device approval in India is primarily managed by the CDSCO, with the DCGI as the final approving authority, supported by State Licensing Authorities for Class A and B devices and the BIS for quality certifications. The MDR 2017 provides a robust framework, ensuring safety and efficacy while aligning with global standards. For manufacturers and importers, navigating this process requires meticulous documentation and compliance with ISO 13485, testing, and licensing requirements.

For expert assistance in Delhi, contact Satish Mehra at +91-8920964801 (WhatsApp or call) to streamline your CDSCO approval process. Visit www.cdsco.gov.in for the latest updates and guidelines. With the right support, businesses can successfully bring safe and innovative medical devices to India’s growing healthcare market.